Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1997-02-21
1999-01-19
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514 12, A61K 3800, A61K 31135
Patent
active
058614389
ABSTRACT:
The present invention provides novel methods of inhibiting bone loss comprising administering to a mammal in need of such treatment an effective amount of a compound of formula I ##STR1## wherein R.sup.1 and R.sup.2 may be the same or different provided that, when R.sup.1 and R.sup.2 are the same, each is a methyl or ethyl group, and, when R.sup.1 and R.sup.2 are different, one of them is a methyl or ethyl group and the other is a hydrogen or a benzyl group; or a pharmaceutically acceptable salt thereof; together with or in combination with parathyroid hormone.
REFERENCES:
patent: 5047431 (1991-09-01), Schickaneder et al.
patent: 5118667 (1992-06-01), Adams et al.
patent: 5254594 (1993-10-01), Niikura et al.
patent: 5384332 (1995-01-01), Fontana
patent: 5441986 (1995-08-01), Thompson
patent: 5455275 (1995-10-01), Fontana
patent: 5550164 (1996-08-01), Fontana
MacLean David B.
Thompson David D.
Benson Gregg C.
Brokke Mervin E.
Goldberg Jerome D.
Pfizer Inc.
Richardson Peter C.
LandOfFree
Combination therapy to prevent bone loss parathyroid hormone and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination therapy to prevent bone loss parathyroid hormone and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy to prevent bone loss parathyroid hormone and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1247163